PA-NHIA YANG-MURRAY: Open Payments
NPI 1700422904 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 18 payments from 13 companies in 2025. Trend: 2023 $394 · 2024 $296 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| ViiV Healthcare Company | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: XYOSTED, FANAPT, TRELEGY ELLIPTA, NURTEC ODT, Auvelity, Wegovy, ZENPEP, ZERBAXA.
Industry payments across MI — which companies pay providers there.
